These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17761650)

  • 21. The neurobiology of childhood spinal muscular atrophy.
    Crawford TO; Pardo CA
    Neurobiol Dis; 1996 Apr; 3(2):97-110. PubMed ID: 9173917
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population.
    Zaldívar T; Montejo Y; Acevedo AM; Guerra R; Vargas J; Garofalo N; Alvarez R; Alvarez MA; Hardiman O
    Neurology; 2005 Aug; 65(4):636-8. PubMed ID: 16116135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.
    El-Khodor BF; Edgar N; Chen A; Winberg ML; Joyce C; Brunner D; Suárez-Fariñas M; Heyes MP
    Exp Neurol; 2008 Jul; 212(1):29-43. PubMed ID: 18455159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical and genetic study of spinal muscular atrophy.
    Mishra VN; Kalita J; Kesari A; Mitta B; Shankar SK; Misra UK
    Electromyogr Clin Neurophysiol; 2004; 44(5):307-12. PubMed ID: 15378871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III.
    Rudnik-Schöneborn S; Hausmanowa-Petrusewicz I; Borkowska J; Zerres K
    Eur Neurol; 2001; 45(3):174-81. PubMed ID: 11306862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal muscular atrophy with congenital fractures: postmortem analysis.
    Van Toorn R; Davies J; Wilmshurst JM
    J Child Neurol; 2002 Sep; 17(9):721-3. PubMed ID: 12503655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic testing for spinal muscular atrophy (SMA) in South Africa.
    Labrum R; Krause A; Rodda J
    S Afr Med J; 2006 Mar; 96(3):200. PubMed ID: 16607426
    [No Abstract]   [Full Text] [Related]  

  • 29. Phenotype and genotype correlation in childhood spinal muscular atrophy.
    Hausmanowa-Petrusewicz I
    Neurol Neurochir Pol; 2001; 35 Suppl 3():29-35. PubMed ID: 12001651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal diagnosis for risk of spinal muscular atrophy.
    Cuscó I; Barceló MJ; Soler C; Parra J; Baiget M; Tizzano E
    BJOG; 2002 Nov; 109(11):1244-9. PubMed ID: 12452462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe spinal muscular atrophy variant associated with congenital bone fractures.
    Felderhoff-Mueser U; Grohmann K; Harder A; Stadelmann C; Zerres K; Bührer C; Obladen M
    J Child Neurol; 2002 Sep; 17(9):718-21. PubMed ID: 12503654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutics development for spinal muscular atrophy.
    Sumner CJ
    NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of SMN1 and NAIP genes in Egyptian patients with spinal muscular atrophy.
    Essawi ML; Effat LK; Shanab GM; Al-Ettribi GM; El-Haronui AA; Karim AM
    Bratisl Lek Listy; 2007; 108(3):133-7. PubMed ID: 17682539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spinal muscular atrophy: SMN protein deficiency].
    Jedrzejowska M
    Neurol Neurochir Pol; 2001; 35(2):289-97. PubMed ID: 11599226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular functions of the SMN complex.
    Kolb SJ; Battle DJ; Dreyfuss G
    J Child Neurol; 2007 Aug; 22(8):990-4. PubMed ID: 17761654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal diagnosis of spinal muscular atrophy in Chinese by genetic analysis of fetal cells.
    Wu T; Ding XS; Li WL; Yao J; Deng XX
    Chin Med J (Engl); 2005 Aug; 118(15):1274-7. PubMed ID: 16117881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic variability in siblings with type III spinal muscular atrophy.
    Muqit MM; Moss J; Sewry C; Lane RJ
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1762-4. PubMed ID: 15548501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between genotype and phenotype in Korean patients with spinal muscular atrophy.
    Cho K; Ryu K; Lee E; Won S; Kim J; Yoo OJ; Hahn S
    Mol Cells; 2001 Feb; 11(1):21-7. PubMed ID: 11266116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid prenatal diagnosis of spinal muscular atrophy by denaturing high-performance liquid chromatography system.
    Shaw SW; Cheng PJ; Chang SD; Lin YT; Hung CC; Chen CP; Su YN
    Acta Obstet Gynecol Scand; 2008; 87(9):960-8. PubMed ID: 18720039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal prediction of spinal muscular atrophy by SMN deletion analysis.
    Dhamcharee V; Mutirangura A; Tannirandom Y; Jongpiputvanich S; Romyanan O
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():186-7. PubMed ID: 11400766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.